Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Human heterologous liver cells (for infusion)

EU orphan designation number: EU/3/10/821   
Active ingredient: Human heterologous liver cells (for infusion)
Indication: Treatment of carbamoyl-phosphate synthase-1 deficiency
Sponsor: Promethera Biosciences
Watson & Crick Hill, 11 Rue Granbonpré, B-1435 Mont-Saint-Guibert, Belgique

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/12/2010 Orphan designation EMA/OD/108/10 (2010)9534 of 17/12/2010
20/06/2016 Transfer of orphan designation EMA/OD/108/10/T/01 (2016)3846 of 16/06/2016